4572 — Carna Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- ¥4bn
- ¥3bn
- ¥636m
Annual cashflow statement for Carna Biosciences, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,102 | -532 | -1,323 | -1,131 | -2,174 |
| Depreciation | |||||
| Non-Cash Items | 94.5 | 57.7 | 84.6 | 47.4 | 148 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -265 | -1,081 | 497 | -630 | 620 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,261 | -1,537 | -708 | -1,677 | -1,375 |
| Capital Expenditures | -68.9 | -41.7 | -126 | -11.5 | -13.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.58 | — | 0.305 | 0.154 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -70.4 | -41.7 | -126 | -11.4 | -13.1 |
| Financing Cash Flow Items | — | 5.64 | 5.71 | -9.29 | 687 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 724 | 1,065 | 367 | 1,182 | 567 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -616 | -481 | -439 | -490 | -781 |